4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0000899243-21-048463
Director sold 325,377 shares at an average $27.36 ($8,901,804)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lettmann Jason Director | 2021-12-13 | Sale | −11,945 | $25.29 | $302,089 | 2,127,969 | I: show line 1 in the form |
| Lettmann Jason Director | 2021-12-13 | Sale | −1,627 | $25.29 | $41,147 | 290,131 | I: show line 2 in the form |
| Lettmann Jason Director | 2021-12-13 | Sale | −17,169 | $26.48 | $454,635 | 2,110,800 | I: show line 3 in the form |
| Lettmann Jason Director | 2021-12-13 | Sale | −2,339 | $26.48 | $61,937 | 287,792 | I: show line 4 in the form |
| Lettmann Jason Director | 2021-12-13 | Sale | −286,496 | $27.49 | $7,875,775 | 2,101,291 | I: show line 5 in the form |
| Lettmann Jason Director | 2021-12-13 | Sale | −1,296 | $27.49 | $35,627 | 286,496 | I: show line 6 in the form |
| Lettmann Jason Director | 2021-12-13 | Sale | −2,196 | $28.37 | $62,301 | 2,099,095 | I: show line 7 in the form |
| Lettmann Jason Director | 2021-12-13 | Sale | −299 | $28.37 | $8,483 | 286,197 | I: show line 8 in the form |
| Open-market sales · 325,377 sh · avg $27.36 · $8,901,804 | |||||||
Loading xslF345X03/doc4.xml…